Extended release formulation and method of treating adrenergic dysregulation

Details for Australian Patent Application No. 2008261957 (hide)

Owner Addrenex Pharmaceuticals, Inc.

Inventors Khayrallah, Moise A.; He, Min Michael; Horacek, H. Joseph

Agent Pizzeys

Pub. Number AU-A-2008261957

PCT Pub. Number WO2008/154339

Priority 60/942,934 08.06.07 US

Filing date 6 June 2008

Wipo publication date 18 December 2008

International Classifications

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

Event Publications

7 January 2010 PCT application entered the National Phase

  PCT publication WO2008/154339 Priority application(s): WO2008/154339

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008261959-Device and method for displaying full azimuth angle domain image data

2008261951-miR-34 regulated genes and pathways as targets for therapeutic intervention